Advaxis Reports First Quarter Fiscal 2019 Financial Results and Provides Clinical Pipeline Update

Go back to Advaxis Reports First Quarter Fiscal 2019 Financial Results and Provides Clinical Pipeline Update

Advaxis (ADXS) Reports Q1 EPS of $0.18

March 12, 2019 8:06 AM EDT

Advaxis (NASDAQ: ADXS) reported Q1 EPS of $0.18, versus ($0.49) reported last year. Revenue for the quarter came in at $19.7 million, versus $2.06 million reported last year.

For earnings history and earnings-related data on Advaxis (ADXS) click here.

... More